Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
EIGR Eiger BioPharmaceuticals, Inc. monthly Stock Chart
EIGR [NASD]
Eiger BioPharmaceuticals, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-2.68 Insider Own0.20% Shs Outstand32.53M Perf Week-14.88%
Market Cap294.88M Forward P/E- EPS next Y-1.61 Insider Trans17.42% Shs Float26.05M Perf Month-4.99%
Income-66.10M PEG- EPS next Q0.55 Inst Own74.50% Short Float5.76% Perf Quarter-17.76%
Sales- P/S- EPS this Y19.30% Inst Trans12.89% Short Ratio2.77 Perf Half Y-27.51%
Book/sh2.29 P/B3.82 EPS next Y-51.90% ROA-63.40% Target Price- Perf Year-30.67%
Cash/sh2.69 P/C3.25 EPS next 5Y- ROE-115.00% 52W Range4.55 - 15.82 Perf YTD-41.28%
Dividend- P/FCF- EPS past 5Y17.00% ROI- 52W High-44.69% Beta1.63
Dividend %- Quick Ratio6.00 Sales past 5Y- Gross Margin- 52W Low92.31% ATR0.74
Employees28 Current Ratio6.00 Sales Q/Q- Oper. Margin- RSI (14)40.57 Volatility8.18% 8.24%
OptionableYes Debt/Eq0.53 EPS Q/Q19.70% Profit Margin- Rel Volume1.24 Prev Close9.04
ShortableYes LT Debt/Eq0.47 Earnings- Payout- Avg Volume541.72K Price8.75
Recom1.00 SMA20-10.43% SMA50-7.10% SMA200-9.61% Volume669,436 Change-3.21%
Jun-26-19Initiated Citigroup Buy $22
Jan-29-19Initiated Robert W. Baird Outperform $47
May-09-18Initiated B. Riley FBR, Inc. Buy $24
Jan-03-18Initiated Ladenburg Thalmann Buy $32
Oct-19-17Initiated ROTH Capital Buy $35
Jun-21-17Resumed Wedbush Outperform $28 → $34
Nov-25-20 08:42AM  
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
PR Newswire
Nov-24-20 03:10PM  
Eiger (EIGR) Gets FDA Approval for Zokinvyin Rare Diseases
Zacks -5.24%
Nov-23-20 08:00AM  
Eiger BioPharmaceuticals Sells Priority Review Voucher for $95 Million
PR Newswire
Nov-20-20 05:53PM  
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
PR Newswire
07:37AM  
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
Benzinga
Nov-17-20 08:00AM  
Eiger Announces Positive Peginterferon Lambda - Lonafarnib Combination End of Study Results from Phase 2 LIFT HDV Study in Late-Breaker Session at The Liver Meeting Digital Experience 2020
PR Newswire
Nov-16-20 04:05PM  
Eiger Announces Case Studies Demonstrating Regression of Liver Fibrosis Following 48 Weeks of Therapy with Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection Presented at The Liver Meeting Digital Experience 2020
PR Newswire
Nov-11-20 08:00AM  
Eiger Bio to Participate in November 2020 Investor Conferences
PR Newswire
Nov-05-20 04:05PM  
Eiger BioPharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
PR Newswire
Nov-02-20 04:30PM  
Eiger Announces Abstracts Highlighting Peginterferon Lambda and Lonafarnib in Chronic Hepatitis Delta Virus (HDV) Infection Accepted for Presentation at The Liver Meeting Digital Experience 2020
PR Newswire
Oct-16-20 10:01AM  
Eiger (EIGR) Up on Positive Results From Coronavirus Study
Zacks
Oct-15-20 03:24PM  
Why Eiger BioPharmaceuticals Stock Skyrocketed Today
Motley Fool +17.52%
08:00AM  
Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19
PR Newswire
Sep-29-20 07:42AM  
Eiger Down on Disappointing Results From Coronavirus Study
Zacks
Sep-28-20 03:47PM  
Why Eiger BioPharmaceuticals Stock Sank Today
Motley Fool -19.51%
03:07PM  
Hedge Funds Are Done Buying Eiger BioPharmaceuticals, Inc. (EIGR)
Insider Monkey
08:00AM  
Eiger Announces Results of Investigator Sponsored Study in Outpatients with Mild and Uncomplicated COVID-19
PR Newswire
Sep-15-20 08:54AM  
Implied Volatility Surging for Eiger BioPharmaceuticals (EIGR) Stock Options
Zacks
Sep-09-20 09:36AM  
Billionaire David Shaw Pours Money Into 3 Strong Buy Stocks
TipRanks
Sep-01-20 08:00AM  
Eiger Bio to Participate in September 2020 Investor Conferences
PR Newswire
Aug-31-20 08:00AM  
Eiger Announces Peginterferon Lambda - Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress 2020
PR Newswire
Aug-19-20 08:49AM  
Eiger BioPharmaceuticals (EIGR) Catches Eye: Stock Jumps 8.6%
Zacks
Aug-17-20 07:40AM  
Insider Buying: The Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Founder Just Bought 4.7% More Shares
Simply Wall St.
Aug-06-20 04:05PM  
Eiger BioPharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
PR Newswire
Aug-03-20 08:00AM  
Eiger BioPharmaceuticals to Participate in Upcoming August 2020 Investor Conferences
PR Newswire +10.95%
Jul-17-20 12:16PM  
Is Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Popular Amongst Institutions?
Simply Wall St.
Jul-12-20 08:14PM  
Did Hedge Funds Make The Right Call On Eiger BioPharmaceuticals, Inc. (EIGR) ?
Insider Monkey
Jul-08-20 12:00PM  
Eiger BioPharma (EIGR) Upgraded to Strong Buy: What Does It Mean for the Stock?
Zacks
Jun-24-20 08:32AM  
Why Eiger BioPharmaceuticals (EIGR) Stock Might be a Great Pick
Zacks -7.72%
Jun-08-20 01:22PM  
Hedge Funds Cant Buy Enough Of Eiger BioPharmaceuticals, Inc. (EIGR)
Insider Monkey
May-29-20 04:05PM  
Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
PR Newswire
May-26-20 04:05PM  
Eiger to Present at Jefferies Virtual Healthcare Conference 2020
PR Newswire
May-19-20 04:05PM  
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
PR Newswire
May-15-20 08:57AM  
Is Eiger BioPharmaceuticals (EIGR) Stock a Solid Choice Right Now?
Zacks +5.21%
Apr-30-20 08:00AM  
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
PR Newswire -8.71%
Apr-22-20 10:05AM  
Will Eiger BioPharmaceuticals Continue to Surge Higher?
Zacks
Apr-09-20 06:08PM  
Clinical trials in the age of COVID: Shelter-in-place, hospital restrictions cause drug study delays
American City Business Journals +7.82%
Apr-01-20 04:05PM  
Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic
PR Newswire -13.24%
Mar-24-20 10:25AM  
Eiger Completes NDA Submission of Progeria Drug Lonafarnib
Zacks +11.88%
Mar-23-20 08:00AM  
Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
PR Newswire +5.37%
Mar-20-20 06:45AM  
Insider Buying: The Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Founder Just Bought US$151k Worth Of Shares
Simply Wall St.
Mar-13-20 08:00AM  
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
PR Newswire +5.54%
Jan-19-20 03:04PM  
Top Insider Buys Highlight for the Week of Jan. 17
GuruFocus.com
Jan-15-20 05:24AM  
Trade Alert: The Chairman Of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), Thomas Dietz, Has Just Spent US$56k Buying Shares
Simply Wall St.
Jan-07-20 08:00AM  
Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer
PR Newswire
Jan-06-20 08:00AM  
Eiger Updates on 2019 Progress and 2020 Milestones Expected
PR Newswire
Dec-16-19 05:15PM  
Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
PR Newswire
Dec-07-19 01:33AM  
Hedge Funds Have Never Been This Bullish On Eiger BioPharmaceuticals, Inc. (EIGR)
Insider Monkey
Nov-15-19 08:00AM  
Eiger to Present at Jefferies 2019 London Healthcare Conference
PR Newswire
Nov-12-19 08:45AM  
Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Results in Hepatitis Delta Virus (HDV) Infection from Phase 2 LIFT Study During Late-Breaker Oral Presentation at AASLD 2019
PR Newswire
Nov-11-19 09:58AM  
Is Eiger BioPharmaceuticals, Inc. (EIGR) A Good Stock To Buy?
Insider Monkey
Nov-07-19 04:05PM  
Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
PR Newswire
Oct-21-19 09:00AM  
Eiger Announces Peginterferon Lambda Combination Therapy for Treatment of Chronic Hepatitis Delta Virus (HDV) Infection to be Featured in a Late-Breaking Oral Presentation at AASLD 2019
PR Newswire
Oct-09-19 09:47AM  
Do Institutions Own Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Shares?
Simply Wall St.
Sep-27-19 08:00AM  
Eiger to Present at Cantor 2019 Global Healthcare Conference
PR Newswire
Aug-29-19 04:05PM  
Eiger BioPharmaceuticals to Participate in September Conferences
PR Newswire
Aug-20-19 08:00AM  
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
PR Newswire
Aug-08-19 04:05PM  
Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
PR Newswire
Aug-05-19 08:00AM  
Eiger BioPharmaceuticals to Participate in Investor Conferences in August
PR Newswire -6.37%
Jul-31-19 08:00AM  
Immunotherapy startup names new CEO
American City Business Journals
Jul-18-19 09:20AM  
Small Peninsula biotech targets big impact on deadly childhood aging disease
American City Business Journals
Jul-11-19 12:42PM  
Need To Know: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Insiders Have Been Buying Shares
Simply Wall St.
Jul-08-19 09:00AM  
What Makes Eiger BioPharma (EIGR) a New Buy Stock
Zacks +12.97%
Jun-20-19 07:08PM  
Hedge Funds Have Never Been This Bullish On Eiger BioPharmaceuticals, Inc. (EIGR)
Insider Monkey
Jun-18-19 07:31AM  
The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale
Benzinga
Jun-17-19 04:16PM  
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Avexitide for Treatment of Post-Bariatric Hypoglycemia (PBH)
PR Newswire
Jun-10-19 08:00AM  
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
PR Newswire
Jun-05-19 08:00AM  
Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development
PR Newswire
May-30-19 08:00AM  
Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
PR Newswire
May-17-19 04:05PM  
Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer
PR Newswire
May-09-19 05:04PM  
Eiger BioPharma: 1Q Earnings Snapshot
Associated Press
04:01PM  
Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
PR Newswire
Apr-30-19 08:00AM  
Eiger to Present at ChinaBio® Partnering Forum 2019
PR Newswire
Apr-26-19 02:43PM  
Do Institutions Own Shares In Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)?
Simply Wall St.
Apr-23-19 03:50PM  
Weekly CFO Buys Highlight
GuruFocus.com
Apr-17-19 10:53PM  
Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock
PR Newswire -5.72%
04:01PM  
Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock
PR Newswire
Apr-15-19 08:00AM  
Eiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of Directors
PR Newswire
Apr-11-19 04:05PM  
Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress 2019
PR Newswire
Mar-26-19 08:00AM  
Eiger BioPharmaceuticals to Participate in Conferences in April
PR Newswire
Mar-25-19 01:30PM  
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019
PR Newswire
Mar-20-19 08:00AM  
Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019
PR Newswire
Mar-15-19 09:04AM  
What Makes Eiger BioPharma (EIGR) a New Buy Stock
Zacks
Mar-14-19 04:19PM  
Eiger BioPharma: 4Q Earnings Snapshot
Associated Press
Mar-13-19 08:00AM  
Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress 2019
PR Newswire
Mar-11-19 08:00AM  
Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit
PR Newswire
Mar-08-19 07:37PM  
[$$] Five Best: Susan Froderberg on Extraordinary Mountain Ascents
The Wall Street Journal
Mar-04-19 07:00AM  
Clinigen and Eiger BioPharmaceuticals Launch Worldwide Managed Access Program for Lonafarnib for Patients with Progeria and Progeroid Laminopathies
Business Wire
Feb-27-19 08:00AM  
Eiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance Officer
PR Newswire
Feb-06-19 08:00AM  
Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan
PR Newswire
Feb-04-19 08:00AM  
Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans
PR Newswire
Jan-07-19 08:00AM  
Eiger BioPharmaceuticals Appoints Regulatory Expert and Industry Veteran Christine Murray, MS, RAC to its Board of Directors
PR Newswire +8.79%
Dec-31-18 07:30AM  
Report: Exploring Fundamental Drivers Behind Cronos Group, Henry Schein, Argo Group International, Eiger BioPharmaceuticals, China Automotive, and Moleculin Biotech New Horizons, Emerging Trends, and Upcoming Developments
GlobeNewswire
Dec-21-18 09:25AM  
Have Insiders Been Buying Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Shares?
Simply Wall St. -5.62%
Dec-19-18 08:00AM  
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies
PR Newswire -5.34%
Dec-18-18 08:00AM  
Eiger Announces PRIME Designation Granted by European Medicines Agency for Lonafarnib for Treatment of Hepatitis Delta Virus Infection
PR Newswire -5.75%
Dec-17-18 08:00AM  
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib for Treatment of Hepatitis Delta Virus (HDV) Infection
PR Newswire
Dec-11-18 02:30PM  
Eiger BioPharmaceuticals Reports on 2018 R&D Day
PR Newswire
Dec-04-18 08:00AM  
Eiger BioPharmaceuticals to Host R&D Day in New York City
PR Newswire
07:59AM  
The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO
Benzinga
Eiger BioPharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase 3 clinical trial to treat hepatitis delta virus (HDV) infection. The company's product candidate also include Lambda, which targets type III interferon receptors that is in Phase 2 clinical trial; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide that has completed phase 2 clinical trial to treat post-bariatric hypoglycemia, as well as in phase 2 clinical trial for the treatment of congenital hyperinsulinism. The company is headquartered in Palo Alto, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Glenn Jeffrey SDirectorAug 12Buy11.425,00057,1035,000Aug 12 06:28 PM
Glenn Jeffrey SDirectorAug 11Buy11.495,00057,46471,355Aug 12 06:28 PM
Dietz Thomas JohnDirectorMar 16Buy4.951,0004,95030,000Mar 17 05:17 PM
Glenn Jeffrey SDirectorMar 16Buy5.0330,000150,81366,355Mar 17 05:16 PM
Mayer Eldon C. IIIEx VP & Chief Commerc. OfficerJan 24Buy13.525,00067,60330,000Jan 30 04:44 PM
Dietz Thomas JohnDirectorJan 10Buy13.944,00055,76024,000Jan 13 08:17 AM
open in yahoo | open in reuters | open in google
affiliate | advertise | contact | privacy | help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.